FDx Advisors, Inc. - SELECT SECTOR SPDR TR ownership

SELECT SECTOR SPDR TR's ticker is XLI and the CUSIP is 81369Y704. A total of 1,076 filers reported holding SELECT SECTOR SPDR TR in Q3 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.4%.

Quarter-by-quarter ownership
FDx Advisors, Inc. ownership history of SELECT SECTOR SPDR TR
ValueSharesWeighting
Q3 2023$1,209
+325.7%
11,922
+350.7%
0.10%
+525.0%
Q2 2023$284
-99.9%
2,645
-36.2%
0.02%
+14.3%
Q1 2022$427,000
+12.1%
4,145
+15.1%
0.01%
+27.3%
Q4 2021$381,0000.0%3,600
-7.6%
0.01%
-8.3%
Q3 2021$381,000
-1.3%
3,895
+3.2%
0.01%
-7.7%
Q2 2021$386,000
+24.9%
3,773
+20.2%
0.01%
+8.3%
Q1 2021$309,000
-60.4%
3,138
-64.4%
0.01%
-62.5%
Q4 2020$780,000
-69.0%
8,810
-79.3%
0.03%
-80.4%
Q1 2020$2,514,000
-78.9%
42,600
-77.0%
0.16%
-83.4%
Q4 2018$11,923,000
+23.3%
185,107
+50.1%
0.98%
+173.0%
Q3 2018$9,671,000
-3.2%
123,357
-11.5%
0.36%
-0.6%
Q2 2018$9,986,000
-9.7%
139,415
-6.3%
0.36%
+9.4%
Q1 2018$11,058,000
+654.8%
148,850
+669.1%
0.33%
+725.0%
Q4 2017$1,465,000
-0.7%
19,355
-6.9%
0.04%0.0%
Q3 2017$1,475,000
-16.8%
20,780
-20.2%
0.04%
-24.5%
Q2 2017$1,773,000
+15.5%
26,037
+10.4%
0.05%
+12.8%
Q1 2017$1,535,000
+42.0%
23,593
+35.8%
0.05%
+51.6%
Q4 2016$1,081,000
+146.8%
17,367
+131.3%
0.03%
+72.2%
Q3 2016$438,000
-8.2%
7,509
-11.9%
0.02%
-18.2%
Q2 2016$477,000
+60.6%
8,521
+59.0%
0.02%
+57.1%
Q1 2016$297,0005,3580.01%
Other shareholders
SELECT SECTOR SPDR TR shareholders Q3 2023
NameSharesValueWeighting ↓
Florin Court Capital LLP 167,700$16,469,81722.30%
P&S Credit Management, L.P. 100,000$9,821,00016.25%
Platt Investment Counsel, LLC 93,652$9,197,58813.08%
Biltmore Wealth Management, LLC 233,402$22,922,4139.89%
MIRABELLA FINANCIAL SERVICES LLP 980,863$96,330,5568.60%
Gates Capital Management 2,750,000$270,077,5008.49%
400 Capital Management LLC 16,900$1,659,7498.12%
Bellwether Advisors, LLC 239,189$23,490,7516.82%
Q3 Asset Management 88,617$8,7035.89%
Beaumont Capital Management, LLC 83,941$8,243,8455.81%
View complete list of SELECT SECTOR SPDR TR shareholders